bremelanotide for hsdd

Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder Danielle Mayer, PharmD, BCACP , and Sarah E. Lynch, PharmD, BCACP Abstract Objective: To review data regarding bremelanotide, a recently approved therapy for hypoactive sexual desire disorder (HSDD). Data...